Goldman Sachs’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,382
| Closed | -$32K | – | 5839 |
|
|
2021
Q4 | $32K | Sell |
3,382
-1,024
| -23% | -$9.69K | ﹤0.01% | 5409 |
|
|
2021
Q3 | $74K | Sell |
4,406
-9,218
| -68% | -$155K | ﹤0.01% | 5111 |
|
|
2021
Q2 | $380K | Buy |
13,624
+11,114
| +443% | +$310K | ﹤0.01% | 4571 |
|
|
2021
Q1 | $56K | Sell |
2,510
-249
| -9% | -$5.56K | ﹤0.01% | 5125 |
|
|
2020
Q4 | $40K | Sell |
2,759
-1,538
| -36% | -$22.3K | ﹤0.01% | 4579 |
|
|
2020
Q3 | $64K | Sell |
4,297
-1,405
| -25% | -$20.9K | ﹤0.01% | 4292 |
|
|
2020
Q2 | $118K | Buy |
+5,702
| New | +$118K | ﹤0.01% | 4141 |
|
|
2020
Q1 | – | Sell |
-4,325
| Closed | -$124K | – | 4503 |
|
|
2019
Q4 | $124K | Buy |
4,325
+2,872
| +198% | +$82.3K | ﹤0.01% | 4104 |
|
|
2019
Q3 | $74K | Buy |
+1,453
| New | +$74K | ﹤0.01% | 4079 |
|
|
2019
Q2 | – | Sell |
-7,175
| Closed | -$474K | – | 4243 |
|
|
2019
Q1 | $474K | Buy |
+7,175
| New | +$474K | ﹤0.01% | 3579 |
|
|
2017
Q2 | – | Sell |
-1,059
| Closed | -$48K | – | 4470 |
|
|
2017
Q1 | $48K | Buy |
+1,059
| New | +$48K | ﹤0.01% | 4221 |
|